Malaria Drug Accelerator (MalDA)
The Malaria Drug Accelerator (MalDA) is a collaboration of 13 scientific laboratories funded by the Bill and Melinda Gates foundation to advance the development of new antimalarial drugs.
MalDA Members
Bill & Melinda Gates Foundation
Gang Liu, Ph.D.
Program Officer
Prof. David Fidock Lab at Columbia University
Manu Vanaerschot, Ph.D.
Pennsylvania State University
Prof. Manuel Llinás
Prof. Dyann Wirth Lab at Harvard University
Amanda Lukens, Ph.D.
Prof. Daniel Goldberg Lab at Washington University in St. Lous
Eva Istvan, Ph.D.
Prof. Elizabeth Winzeler Lab at UC San Diego
Sabine Ottilie, Ph.D.
Program Manager
GlaxoSmithKline
Francisco Javier Gamo-Benito, Ph.D.
Wellcome Trust Sanger Institute
Marcus Lee, Ph.D.
The Medicines For Malaria Venture
Jeremy Burrows, Ph.D.
Global Health Drug Discovery Institute
Xin-Jie Chu, Ph.D.
Structure-Based Drug Discovery Consortium
Chris Walpole, Ph.D.
MIT
Prof. Jacquin Niles, Ph.D.
Drug Discovery Unit, University of Dundee
Ian Gilbert, Ph.D.
Message us for inquiries regarding the MalDA project: saottilie@ucsd.edu
